Stereotactic radiosurgery at St. Batholomew's hospital: Third quinquennial review

British Journal of Radiology

Volumn 78, Issue 929, 2005, Pages 384-393

  El Hamri, A K ^a   Monk, J ^a   Plowman, P N ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC NEURINOMA; ARTERIOVENOUS MALFORMATION; AUTOMATION; BRAIN METASTASIS; BRAIN TUMOR; CAVERNOUS HEMANGIOMA; CLINICAL PRACTICE; CLINICAL RESEARCH; COLLIMATOR; COMPUTER PROGRAM; CRANIOPHARYNGIOMA; DIGITAL SUBTRACTION ANGIOGRAPHY; EQUIPMENT DESIGN; HEALTH CARE FACILITY; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS ADENOMA; INTERMETHOD COMPARISON; MEDICAL INSTRUMENTATION; MENINGIOMA; NEUROFIBROMATOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIOSURGERY; REVIEW; STEREOTAXIC SURGERY; TREATMENT PLANNING; UNITED KINGDOM;

ADENOMA; ARTERIOVENOUS MALFORMATIONS; BRAIN DISEASES; BRAIN NEOPLASMS; CRANIOPHARYNGIOMA; HUMANS; LONDON; MAGNETIC RESONANCE IMAGING; MENINGIOMA; RADIOSURGERY;

EID: 18844451484     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/25963871     Document Type: Review

References (52)

1. Leksell L. A stereotaxic apparatus for intracerebral surgery. Acta Chir Scand 1949;99:231.
2. Leksell L. Cerebral radiosurgery I. Gamma thalamotomy in two cases of intractable pain. Acta Chir Scand 1968;134:585-95.
3. Walton L, Bomford CK, Ramsden D. The Sheffield stereotactic radiosurgery unit: physical characteristics and principles of operation. Br J Radiol 1987;60:897-906.
4. Gerhard A, Horstmann MD, Shogens H, Albertus TCJ, Van Eck MD, Kreiner HJ, et al. First clinical experience with automatic position system and Leksell Gamma Knife Model C. J Neurosurg 2000;93(Suppl. 3):193-7.
5. Levivier M, Wikier D, Goldman S, David P, Metens T, Massager N, et al. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the Gamma Knife: early experience with brain tumours. J Neurosurg 2000;93(Suppl. 3):233-8.
6. Sims E, Doughty D, Macaulay E, Royle N, Wraith C, Darlison R, et al. Stereotactically delivered cranial radiation therapy: a ten year experience of linac based radiosurgery in the UK. Clin Oncol 1999;11:303-20.
7. St. George EJ, Plowman PN. The role of Gamma Knife and PET in neuro-oncology. CME Cancer Med 2002;1:3-8.
8. Plowman PN. Pituitary adenoma radiotherapy - when, who and how? Clin Endocrinol 1999;51:265-71.
9. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 1998;88:1002-8.
10. Kondziolka D, Patel A, Lunsford D, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus whole brain radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-34.
11. Adams EJ, Cosgrove VP, Shepherd SF, et al. Comparison of a multileaf collimator with conformal blocks for the delivery of stereotactically guided conformal radiotherapy. Radiother Oncol 1999;51:205-9.
12. Plowman PN, Doughty D. Stereotactic radiosurgery X. Clinical isodosimetry of gamma knife versus linear accelerator X-knife for pituitary and acoustic tumours. Clin Oncol 1999;11:321-9.
13. Monk JE, Perks JR, Doughty D, Plowman PN. Comparison of a micro-multileaf collimator with a 5mm leaf width collimator for intracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1443-9.
14. Perks JL, St. George EJ, El Hamri K, Blackburn P, Plowman PN. Stereotactic radiosurgery XVI. Isodosimetric comparison of Gamma Knife versus linear accelerator micro-leaf MLC stereotactic radiotherapy methods for the therapy of acoustic neuroma - potential clinical importance. Int J Radiat Oncol Biol Phys 2003;57:1450-9.
15. El Hamri AK, Blackburn P, Perks JP, Plowman PN. Relationship of conformity index (CI) and minimum target dose (min TD) for two stereotactic treatment delivery systems. Proc Eur Gamma Knife Soc (Lugo, Italy. Dec 2003) Abstr.
16. Perks J, St. George EJ, Doughty D, Plowamn PN. Is distortion correction necessary for digital subtraction angiography in the Gamma Knife treatment of intracranial arteriovenous malformations. Stereotact Funct Neurosurg 2001;76:94-105.
17. St George EJ, Butler P, Plowman PN. Can magnetic resonance imaging alone accurately define the arteriovenous nidus for gamma knife radiosurgery? J Neurosurg 2002; 97(Suppl. 5):464-70.
18. Guo WY, Nordell B, Karlsson B, et al. Target delineation in radiosurgery for cerebral arteriovenous malformations. Acta radiol 1993;34:457-63.
19. Plowman PN. Radiation therapy for vascular malformations - a changing scene. Clin Oncol 2002;14:91-6.
20. St George J, Perks J, Plowman PN. Stereotactic radiosurgery XV. The role of the haemosiderin ring in the development of adverse reactions following radiosurgery for intracranial cavernous malformations - a hypothesis. Br J Neurosurg 2002;16:385-91.
21. Madreperla SA, Hungerford JL, Plowman PN. Choroidal haemangiomas: visual and anatomic results of treatment by photocoagulation or radiotherapy. Ophthalmology 1997;104: 1773-9.
22. Plowman PN, Hungerford JL. Radiotherapy for ocular angioma. Br J Ophthalmol 1997;81:258-9.
23. Nelson JM, Stevens RG. Ferritin ion increases killing of Chinese hamster ovary cells by x-irradiation. Cell Prolif 1992;25:579-85.
24. Hornsey S, Myers R, Jenkinson T. The reduction of radiation damage to the spinal cord by post-irradiation administration of vaso-active drugs. Int J Radiat Oncol Biol Phys 1990;18:1437-42.
25. Kondziolka D, Lunsford D, McLaughlin MR, et al. Long term outcomes after radiosurgery for acoustic neuroma. N Engl J Med 1998;339:1426-33.
26. Fuss M, Debus J, Lohr F, et al. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 2000;48:1381-7.
27. Plowman PN. Post-radiation sensorineuronal hearing loss. Int J Radiat Oncol Biol Phys 2002;52:589-91.
28. Rowlands RG, Plowman PN, Millard R, Wareing M. Recovery of hearing in a dead ear following stereotactic radiosurgery for vestibular schwannoma. Proc Fourth International conference on vestibular schwannoma and other CPA lesions. (Cambridge UK, July 2003). Abstr.
29. Baser ME, Evans DGR, Jackler RK, Sujansky E, Rubinstein A. Malignant nervous system tumours, radiotherapy and neurofibromatosis. Br J Cancer 2000;82:998-1002.
30. Plowman PN, Evans DGR. Stereotactic radiosurgery XI. Acoustic neuroma therapy and radiation oncogenesis. Br J Neurosurg 2000;14:93-5.
31. Knudson AG. Mutation and cancer: a statistical study of retinoblastoma. Proc Natl Acad Sci 1971;68:820-3.
32. Blackburn TPD, Perks JR, Plowman PN. Is there a predisposition to radiation oncogenesis in NF-2 patients and is the situation comparable to hereditary retinoblastoma. Proc Europ Gamma Knife Soc Mtg. Nov 2002 (London), Abstr.
33. Rowe JG, Radatz M, Walton L, Kemeny AA. Stereotactic radiosurgery for Type 2 neurofibromatosis acoustic neuromas: patient selection and tumour size. Stereotact Funct Neurosurg 2002;79:107-16.
34. Rowe JG, Radatz MWR, Walton L, Soanes T, Rodgers J, Kemeny AA. Clinical experience with Gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psych 2003;74:1288-93.
35. Swords FM, Allan CA, Plowman PN, Evanson J, Chew SL, Grossman AB, et al. Steretactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. J Clin Endocrinol Metab 2003;88:5334-40.
36. Plowman PN. Pituitary adenoma radiotherapy. Clin Endocrinol 1999;51:265-7.
37. Storr HL, Plowman PN, Carroll PV, Krassas GE, Afshar F, Besser GM, et al. Clinical and endocrine responses to pituitary radiotherapy in paediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab 2003;88:34-7.
38. Degerblad M, Rahn T, Bergstrand G, Thoren M. Long term results of stereotactic radiosurgery to the pituitary gland in Cushing's disease. Acta Endocrinologica 1986;112:310-4.
39. Ulfarrson E, Roberts M, Rahn T, Linquist M, Thoren M, Lindquist C. Gamma Knife surgery for craniopharyngiomas: long term results of the first patients. Proc 11th Annual Meeting of the Leksell Gamma Knife Society, Prague, May 2002.
40. Jackson ASN, St. George EJU, Hayward RJ, Plowman PN. Stereotactic radiosurgery XVII. Recurrent intrasellar craniopharyngioma. Br J Neurosurg 2003;17:138-43.
41. Blackburn TPD, Doughty D, Plowman PN. Stereotactic intracavity therapy of recurrent cystic craniopharyngioma by instillation of 90-Yttrium. Br J Neurosurg 1999;13:359-65.
42. Tsao N, Sultanem K, Chiu D, Copps F, Dixon P, Easton D, et al. Supportive care management of brain metastases: what is known and what we need to know. Clin Oncol 2003;15:429-34.
43. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastasis trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
44. Marcou Y, Lindquist C, Adams C, Retsas S, Plowman PN. What is optimal therapy of brain metastases? Clin Oncol 2001;13:105-11.
45. Shaw EG. Radiotherapeutic management of multiple brain metastases: 3000 in 10 whole brain is no longer a no brainer. Int J Radiat Oncol Biol Phys 1999;45:253-4.
46. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase 111 results of RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
47. Blackburn TPD, El Hanmri K, Boxhall YL, Barett S, Plowman PN, Bullock P. Acute cerebral oedema during radiosurgery - natural history or complication? Proc Eur Gamma Knife meeting (London 2002 - Abstr.).
48. Blackburn TPD, Jeanson De Damoiseau KM, Sabin HI, Plowman PN. Facial spasm complicating stereotactic radiosurgery/therapy for acoustic schwannoma. World Gamma Knife Users Meeting (Vienna, 2004) Abstr.
49. Plowman PN. Stereotactic radiosurgery VIII. The classification of post-radiosurgery reactions. Br J Neurosurg 1999;13:256-64.
50. Hopewell JW, Van den Aardweg GJM, Morris GM. Unsaturated lipids as modulators of radiation damage in normal tissues. In: Horobin DF, editor. New approaches to cancer treatment: unsaturated lipids and photodynamic therapy. London: Churchill Communication Europe, 1994; 88-106.
51. El Agamawi AY, Hopewell JW, Plowman PN, Rezvani M, Wilding D. Modulation of normal tissue response to radiation. Br J Radiol 1996;69:374-5.
52. Sims EC, Plowman PN. Stereotactic radiosurgery XII. Large AVM and the failure of the radiation response modifier gamma linolenic acid to improve the therapeutic ratio. Br J Neurosurg 2001;15:28-34.